Literature DB >> 8233823

In vivo analysis of Pim-1 deficiency.

P W Laird1, N M van der Lugt, A Clarke, J Domen, K Linders, J McWhir, A Berns, M Hooper.   

Abstract

The Pim-1 proto-oncogene encodes a highly conserved serine/threonine phosphokinase which is predominantly expressed in hematopoietic organs and gonads in mammals. Overexpression of Pim-1 predisposes to lymphomagenesis in mice. To develop a further understanding of Pim-1 in molecular terms, as well as in terms of its potential role in hematopoietic development, we have generated mice deficient in Pim-1 function. Pim-1-deficient mice are ostensibly normal, healthy and fertile. Detailed comparative analyses of the hematopoietic systems of the mutant mice and their wild-type littermates showed that they are indistinguishable for most of the parameters studied. Our analyses revealed one unexpected phenotype that correlated with the level of Pim-1 expression: Pim-1 deficiency correlated with a erythrocyte microcytosis, whereas overexpression of Pim-1 in E mu-Pim-1-transgenic mice resulted in erythrocyte macrocytosis. In order to confirm that the observed decrease in erythrocyte Mean Cell Volume (MCV) was attributable to the Pim-1 deficiency, we developed mice transgenic for a Pim-1 gene construct with its own promoter and showed that this transgene could restore the low erythrocyte Mean Cell Volume observed in the Pim-1-deficient mice to near wild-type levels. These results might be relevant to the observed involvement of the Pim-1 gene in mouse erythroleukemogenesis. The surprising lack of a readily observed phenotype in the lymphoid compartment of the Pim-1-deficient mice, suggests a heretofore unrecognized degree of in vivo functional redundancy of this highly conserved proto-oncogene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8233823      PMCID: PMC331501          DOI: 10.1093/nar/21.20.4750

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  32 in total

1.  A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Authors:  J E TILL; E A McCULLOCH
Journal:  Radiat Res       Date:  1961-02       Impact factor: 2.841

2.  Characterization of the testes-specific pim-1 transcript in rat.

Authors:  D Wingett; R Reeves; N S Magnuson
Journal:  Nucleic Acids Res       Date:  1992-06-25       Impact factor: 16.971

3.  The human PIM-1 gene product is a protein serine kinase.

Authors:  R Padma; L Nagarajan
Journal:  Cancer Res       Date:  1991-05-01       Impact factor: 12.701

4.  Simplified mammalian DNA isolation procedure.

Authors:  P W Laird; A Zijderveld; K Linders; M A Rudnicki; R Jaenisch; A Berns
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

5.  Very high frequency of lymphoma induction by a chemical carcinogen in pim-1 transgenic mice.

Authors:  M Breuer; R Slebos; S Verbeek; M van Lohuizen; E Wientjens; A Berns
Journal:  Nature       Date:  1989-07-06       Impact factor: 49.962

6.  Recombinant human pim-1 protein exhibits serine/threonine kinase activity.

Authors:  D Hoover; M Friedmann; R Reeves; N S Magnuson
Journal:  J Biol Chem       Date:  1991-07-25       Impact factor: 5.157

7.  E mu N- and E mu L-myc cooperate with E mu pim-1 to generate lymphoid tumors at high frequency in double-transgenic mice.

Authors:  T Möröy; S Verbeek; A Ma; P Achacoso; A Berns; F Alt
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

8.  Carcinogen-induced lymphomagenesis in pim-1 transgenic mice: dose dependence and involvement of myc and ras.

Authors:  M Breuer; E Wientjens; S Verbeek; R Slebos; A Berns
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

9.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

Authors:  R Amson; F Sigaux; S Przedborski; G Flandrin; D Givol; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow.

Authors:  R R Hardy; C E Carmack; S A Shinton; J D Kemp; K Hayakawa
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

View more
  43 in total

1.  Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP.

Authors:  U Konietzko; G Kauselmann; J Scafidi; U Staubli; H Mikkers; A Berns; M Schweizer; R Waltereit; D Kuhl
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  For better or for worse: the role of Pim oncogenes in tumorigenesis.

Authors:  Martijn C Nawijn; Andrej Alendar; Anton Berns
Journal:  Nat Rev Cancer       Date:  2010-12-09       Impact factor: 60.716

3.  Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.

Authors:  Susann Herzog; Matthias Alexander Fink; Kerstin Weitmann; Claudius Friedel; Stefan Hadlich; Sönke Langner; Katharina Kindermann; Tobias Holm; Andreas Böhm; Eskil Eskilsson; Hrvoje Miletic; Markus Hildner; Michael Fritsch; Silke Vogelgesang; Christoph Havemann; Christoph Alexander Ritter; Henriette Elisabeth Meyer zu Schwabedissen; Bernhard Rauch; Wolfgang Hoffmann; Heyo Klaus Kroemer; Henry Schroeder; Sandra Bien-Möller
Journal:  Neuro Oncol       Date:  2014-08-25       Impact factor: 12.300

4.  A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer.

Authors:  Jong-Eun Kim; Joe Eun Son; Hyein Jeong; Dong Joon Kim; Sang Kwon Seo; Eunjung Lee; Tae Gyu Lim; Jong Rhan Kim; Hanyong Chen; Ann M Bode; Ki Won Lee; Zigang Dong
Journal:  Cancer Res       Date:  2015-05-06       Impact factor: 12.701

Review 5.  PIM1: a promising target in patients with triple-negative breast cancer.

Authors:  Wen Zhao; RuiYue Qiu; Pan Li; Jin Yang
Journal:  Med Oncol       Date:  2017-07-18       Impact factor: 3.064

6.  Pim1 serine/threonine kinase regulates the number and functions of murine hematopoietic stem cells.

Authors:  Ningfei An; Ying-Wei Lin; Sandeep Mahajan; Joshua N Kellner; Yong Wang; Zihai Li; Andrew S Kraft; Yubin Kang
Journal:  Stem Cells       Date:  2013-06       Impact factor: 6.277

Review 7.  Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis.

Authors:  Achille Iolascon; Luigia De Falco; Carole Beaumont
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

8.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

Review 9.  Transgenic and gene knockout mice in cancer research.

Authors:  J L Viney
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

10.  Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.

Authors:  Harald Mikkers; Martijn Nawijn; John Allen; Conny Brouwers; Els Verhoeven; Jos Jonkers; Anton Berns
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.